Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Hypertension

Free Subscription Articles published in Circulation Retrieve available abstracts of 85 articles: HTML format

Single Articles

November 2023
1. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
   Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
   Circulation. 2023;148:1825-1826.
   PubMed    
   
   
   
2. LI G, Chen H, Ren C
   Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
   Circulation. 2023;148:1823-1824.
   PubMed    
   
   
   
3. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
   A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
   Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
   PubMed    
   
   
   
4. KITT J, Krasner S, Barr L, Frost A, et al
   Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Sub-study.
   Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067597.
   PubMed     Abstract available
   
   
   October 2023
5. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
   Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
   Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
   PubMed     Abstract available
   
   
   September 2023
6. KUEHN BM
   Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
   Circulation. 2023;148:852-854.
   PubMed    
   
   
   August 2023
7. WANG Z, Du X, Hua C, Li W, et al
   The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial.
   Circulation. 2023;148:565-574.
   PubMed     Abstract available
   
   
   July 2023
8. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
   Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET
   Circulation. 2023;148:375-377.
   PubMed    
   
   
   
9. 
   Correction to: Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
   Circulation. 2023;148:e2.
   PubMed    
   
   
   May 2023
10. GARDNER CD, Vadiveloo MK, Petersen KS, Anderson CAM, et al
    Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:1715-1730.
    PubMed     Abstract available
    
    
    
11. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
    Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717.
    PubMed     Abstract available
    
    
    
12. 
    Correction to: Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.
    Circulation. 2023;147:e718.
    PubMed    
    
    
    April 2023
13. GUIGNABERT C, Savale L, Boucly A, Thuillet R, et al
    Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
    Circulation. 2023 Apr 25. doi: 10.1161/CIRCULATIONAHA.122.061501.
    PubMed     Abstract available
    
    
    
14. WALTERS R, Vasilaki E, Aman J, Chen CN, et al
    SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.
    Circulation. 2023 Apr 17. doi: 10.1161/CIRCULATIONAHA.122.061940.
    PubMed     Abstract available
    
    
    
15. MITCHELL BD, Whitlatch HB
    Decoding Hypertension Through Primary Aldosteronism.
    Circulation. 2023;147:1110-1111.
    PubMed    
    
    
    March 2023
16. PITT B, Vaidya A
    Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension.
    Circulation. 2023;147:991-992.
    PubMed    
    
    
    
17. HINKLE SN, Schisterman EF, Liu D, Pollack AZ, et al
    Pregnancy Complications and Long-Term Mortality in a Diverse Cohort.
    Circulation. 2023;147:1014-1025.
    PubMed     Abstract available
    
    
    
18. RAJAGOPAL S, Ruetzler K, Ghadimi K, Horn EM, et al
    Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 16. doi: 10.1161/CIR.0000000000001136.
    PubMed     Abstract available
    
    
    February 2023
19. NAITO T, Inoue K, Sonehara K, Baba R, et al
    Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Study.
    Circulation. 2023 Feb 21. doi: 10.1161/CIRCULATIONAHA.122.062349.
    PubMed     Abstract available
    
    
    
20. CHIN KM, Santiago-Munoz P
    Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?
    Circulation. 2023;147:562-564.
    PubMed    
    
    
    
21. BADROV MB, Yoo JK, Hissen SL, D'Souza AW, et al
    Muscle Sympathetic Action Potential Firing Patterns During Normotensive and Hypertensive Pregnancy: A Longitudinal Assessment.
    Circulation. 2023;147:611-613.
    PubMed    
    
    
    
22. ZHANG Q, Zhu F, Shi G, Hu C, et al
    Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
    Circulation. 2023;147:549-561.
    PubMed     Abstract available
    
    
    
23. GRASHOW R, Tan CO, Izzy S, Taylor HA Jr, et al
    Association Between Concussion Burden During Professional American-style Football and Post-career Hypertension.
    Circulation. 2023 Feb 7. doi: 10.1161/CIRCULATIONAHA.122.063767.
    PubMed    
    
    
    
24. KUEHN BM
    No Benefit Seen for Nighttime Dosing Over Morning Dosing for Antihypertensive Medications.
    Circulation. 2023;147:512-514.
    PubMed    
    
    
    January 2023
25. BERRY JD, Chen H, Nambi V, Ambrosius WT, et al
    Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
    Circulation. 2023;147:310-323.
    PubMed     Abstract available
    
    
    December 2022
26. OBEL LM, Lindholt JS, Lasota AN, Jensen HK, et al
    Clinical Characteristics, Incidences, and Mortality Rates for Type A and B Aortic Dissections: A Nationwide Danish Population-Based Cohort Study From 1996 to 2016.
    Circulation. 2022;146:1903-1917.
    PubMed     Abstract available
    
    
    
27. BORN E, Lipskaia L, Breau M, Houssaini A, et al
    Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Circulation. 2022 Dec 14. doi: 10.1161/CIRCULATIONAHA.122.058794.
    PubMed     Abstract available
    
    
    November 2022
28. AGARWAL R
    Hydrochlorothiazide Versus Chlorthalidone: What Is the Difference?
    Circulation. 2022;146:1641-1643.
    PubMed    
    
    
    
29. ZHOU W, Liu K, Zeng L, He J, et al
    Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
    Circulation. 2022 Nov 17. doi: 10.1161/CIRCULATIONAHA.122.061900.
    PubMed     Abstract available
    
    
    
30. 
    Correction to: Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
    Circulation. 2022;146:e280.
    PubMed    
    
    
    October 2022
31. ERCU M, Mucke MB, Pallien T, Marko L, et al
    Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
    Circulation. 2022 Oct 19:101161CIRCULATIONAHA122060210.
    PubMed     Abstract available
    
    
    September 2022
32. BAI C, Su M, Zhang Y, Lin Y, et al
    Oviductal Glycoprotein 1 Promotes Hypertension by Inducing Vascular Remodeling Through an Interaction With MYH9.
    Circulation. 2022 Sep 29:101161CIRCULATIONAHA121057178.
    PubMed     Abstract available
    
    
    
33. 
    Correction to: Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2022;146:e168.
    PubMed    
    
    
    
34. VIDAL-PETIOT E
    Thresholds for Hypertension Definition, Treatment Initiation, and Treatment Targets: Recent Guidelines at a Glance.
    Circulation. 2022;146:805-807.
    PubMed    
    
    
    
35. GOTO S, Solanki D, John JE, Yagi R, et al
    Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection.
    Circulation. 2022;146:755-769.
    PubMed     Abstract available
    
    
    August 2022
36. AGARWAL R, Sinha AD, Tu W
    Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.
    Circulation. 2022;146:718-720.
    PubMed    
    
    
    
37. CAO N, Lan C, Chen C, Xu Z, et al
    Prenatal Lipopolysaccharides Exposure Induces Transgenerational Inheritance of Hypertension.
    Circulation. 2022 Aug 25:CIRCULATIONAHA122059891.
    PubMed     Abstract available
    
    
    
38. BRUSCA SB, Elinoff JM, Zou Y, Jang MK, et al
    Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
    Circulation. 2022 Aug 25:101161CIRCULATIONAHA121056719.
    PubMed     Abstract available
    
    
    
39. YAKU A, Inagaki T, Asano R, Okazawa M, et al
    Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Circulation. 2022 Aug 23:101161CIRCULATIONAHA122059435.
    PubMed     Abstract available
    
    
    
40. RUFFENACH G, Medzikovic L, Aryan L, Li M, et al
    HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
    Circulation. 2022 Aug 22:101161CIRCULATIONAHA122059591.
    PubMed     Abstract available
    
    
    
41. TOUYZ RM
    TRPV4 Channel-Regulated Microdomains Define a New Paradigm in Hypertension.
    Circulation. 2022;146:565-568.
    PubMed    
    
    
    
42. CHEN YL, Daneva Z, Kuppusamy M, Ottolini M, et al
    Novel Smooth Muscle Ca(2+)-Signaling Nanodomains in Blood Pressure Regulation.
    Circulation. 2022;146:548-564.
    PubMed     Abstract available
    
    
    
43. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.
    Circulation. 2022 Aug 11:101161CIRCULATIONAHA121054602.
    PubMed     Abstract available
    
    
    
44. WELLS CE, Cunningham FG
    Treatment of Chronic Hypertension in Pregnancy: Is It Time for a Change?
    Circulation. 2022;146:433-434.
    PubMed    
    
    
    July 2022
45. WANG Y, Feng L, Zeng G, Zhu H, et al
    Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial.
    Circulation. 2022;146:303-315.
    PubMed     Abstract available
    
    
    
46. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    PubMed     Abstract available
    
    
    
47. TREMBLAY E, Gosselin C, Mai V, Lajoie AC, et al
    Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2022 Jul 8:101161CIRCULATIONAHA121058635.
    PubMed     Abstract available
    
    
    May 2022
48. BROOK RD, Scirica BM, Levy PD
    "The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension.
    Circulation. 2022;145:1629-1631.
    PubMed    
    
    
    March 2022
49. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available
    
    
    
50. STEWART RH, Cox CS Jr, Allen SJ, Laine GA, et al
    Myocardial Edema Provides a Link Between Pulmonary Arterial Hypertension and Pericardial Effusion.
    Circulation. 2022;145:793-795.
    PubMed    
    
    
    
51. KANDZARI DE, Mahfoud F, Weber MA, Townsend R, et al
    Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
    Circulation. 2022;145:847-863.
    PubMed     Abstract available
    
    
    
52. LECHUGA-VIECO AV, Latorre-Pellicer A, Calvo E, Torroja C, et al
    Heteroplasmy of Wild Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2022 Mar 3. doi: 10.1161/CIRCULATIONAHA.121.056286.
    PubMed     Abstract available
    
    
    
53. NIENABER CA, Yuan X
    Taming Hypertension to Prevent Aortic Dissection: Universal Recognition of a "New Normal" Blood Pressure?
    Circulation. 2022;145:645-647.
    PubMed    
    
    
    February 2022
54. VEITH C, Varturk-Ozcan I, Wujak M, Hadzic S, et al
    Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Circulation. 2022 Feb 17. doi: 10.1161/CIRCULATIONAHA.121.057001.
    PubMed     Abstract available
    
    
    
55. HONIGBERG MC, Zekavat SM, Raghu VK, Natarajan P, et al
    Microvascular Outcomes in Women With a History of Hypertension in Pregnancy.
    Circulation. 2022;145:552-554.
    PubMed    
    
    
    
56. MACINTYRE IM, Turtle EJ, Farrah TE, Graham C, et al
    Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
    Circulation. 2022;145:416-423.
    PubMed     Abstract available
    
    
    
57. SMITH SM, Cooper-DeHoff RM
    Acetaminophen-Induced Hypertension: Where Have All the "Safe" Analgesics Gone?
    Circulation. 2022;145:424-426.
    PubMed    
    
    
    January 2022
58. LAFFIN LJ, Kaufman HW, Chen Z, Niles JK, et al
    Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic.
    Circulation. 2022;145:235-237.
    PubMed    
    
    
    November 2021
59. 
    Correction to: National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021;144:e333.
    PubMed    
    
    
    
60. NAEIJE R
    Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e328-e329.
    PubMed    
    
    
    
61. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
    Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e330-e331.
    PubMed    
    
    
    
62. HIBINO M, Otaki Y, Kobeissi E, Pan H, et al
    Blood Pressure, Hypertension and The Risk of Aortic Dissection Incidence and Mortality: results from the Japan-Specific Health Checkups Study, the UK Biobank Study and a Meta-analysis of Cohort Studies.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.056546.
    PubMed     Abstract available
    
    
    
63. LU Y, Wang Y, Spatz ES, Onuma O, et al
    National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057056.
    PubMed    
    
    
    October 2021
64. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available
    
    
    
65. WEI J, Fang D
    Letter by Wei and Fang Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e236.
    PubMed    
    
    
    
66. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Response by Filippini et al to Letter Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e237.
    PubMed    
    
    
    September 2021
67. BLUMENTHAL JA, Hinderliter AL, Smith PJ, Mabe S, et al
    Effects of Lifestyle Modification on Patients With Resistant Hypertension: Results of the TRIUMPH Randomized Clinical Trial.
    Circulation. 2021 Sep 27. doi: 10.1161/CIRCULATIONAHA.121.055329.
    PubMed    
    
    
    
68. LEO F, Suvorava T, Heuser SK, Li J, et al
    Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure.
    Circulation. 2021;144:870-889.
    PubMed     Abstract available
    
    
    August 2021
69. LEOPOLD JA
    Nanoparticle-Facilitated Gene Delivery in Congenital Pulmonary Vascular Disease: Roadmap for Other Forms of Pulmonary Hypertension.
    Circulation. 2021;144:556-558.
    PubMed    
    
    
    July 2021
70. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    PubMed     Abstract available
    
    
    June 2021
71. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    PubMed     Abstract available
    
    
    
72. RAYNER BL, Spence JD
    Physiological Treatment of Hypertension in Black Patients: Time for Action.
    Circulation. 2021;143:2367-2369.
    PubMed    
    
    
    
73. KAZI DS, Wei PC, Penko J, Bellows BK, et al
    Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value.
    Circulation. 2021;143:2406-2408.
    PubMed    
    
    
    
74. JOSEPH JJ, Pohlman NK, Zhao S, Kline D, et al
    Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.
    Circulation. 2021;143:2355-2366.
    PubMed     Abstract available
    
    
    
75. SUN F, Wang G, Pradhan A, Xu K, et al
    Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2021 Jun 11. doi: 10.1161/CIRCULATIONAHA.121.053980.
    PubMed     Abstract available
    
    
    
76. BISSERIER M, Mathiyalagan P, Zhang S, Elmastour F, et al
    Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Circulation. 2021 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047978.
    PubMed     Abstract available
    
    
    May 2021
77. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    PubMed    
    
    
    
78. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    PubMed    
    
    
    
79. BROOK RD, Levy PD, Jamerson KA
    Mission "UnACCOMPLISHed": Optimal Antihypertensive Therapy.
    Circulation. 2021;143:1932-1934.
    PubMed    
    
    
    
80. KARIO K, Ferdinand KC, Vongpatanasin W
    Are SGLT2 Inhibitors New Hypertension Drugs?
    Circulation. 2021;143:1750-1753.
    PubMed    
    
    
    April 2021
81. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    PubMed     Abstract available
    
    
    
82. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.
    Circulation. 2021;143:1542-1567.
    PubMed     Abstract available
    
    
    
83. BRYANT KB, Moran AE, Kazi DS, Zhang Y, et al
    Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.051683.
    PubMed     Abstract available
    
    
    
84. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed     Abstract available
    
    
    November 2020
85. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
    Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.